NEWS: 公告在東京證券交易所JASDAQ標準市場新上市

表紙
市場調查報告書

細胞治療的全球市場 - 產業分析與預測:2020年∼2026年

Global Cell Therapy Market By Therapy Type, By Therapeutic Area, By End User, By Cell Type, By Regional Outlook, Industry Analysis Report and Forecast, 2020 - 2026

出版商 KBV Research 商品編碼 1001775
出版日期 內容資訊 英文 270 Pages
訂單完成後即時交付
價格
細胞治療的全球市場 - 產業分析與預測:2020年∼2026年 Global Cell Therapy Market By Therapy Type, By Therapeutic Area, By End User, By Cell Type, By Regional Outlook, Industry Analysis Report and Forecast, 2020 - 2026
出版日期: 2021年03月31日內容資訊: 英文 270 Pages
簡介

全球細胞治療的市場規模在2026年前預計將達到285億美元,在預測期間內預計將以年複合成長率26.2%的速度成長。細胞療法被認為是基於用活性和功能性細胞替代功能障礙或患病細胞的技術。在這些先進的療法中使用了幹細胞。

本報告提供全球細胞治療市場相關調查分析,提供市場概要,各市場區隔的市場分析,各地區的市場分析,主要企業等相關的系統性資訊。

目錄

第1章 市場範圍與調查手法

第2章 市場概要

  • 簡介
  • 影響市場的主要原因

第3章 競爭分析:世界

  • KBV基數矩陣
  • 最近的產業的策略性發展
  • 主要成功策略

第4章 全球細胞治療市場:各治療類型

  • 自體
  • 同種異體

第5章 全球細胞治療市場:各治療領域

  • 惡性腫瘤
  • 自體免疫疾病
  • 肌肉骨骼系統障礙
  • 皮膚科
  • 其他

第6章 全球細胞治療市場:各終端用戶

  • 學術·研究機關
  • 醫院·診所

第7章 全球細胞治療市場:各細胞類型

  • 幹細胞
  • 臍帶來源細胞
  • 脂肪來源幹細胞
  • 非幹細胞
  • 骨髓細胞
  • 血液細胞
  • 其他

第8章 全球細胞治療市場:各地區

  • 北美
  • 歐洲
  • 亞太地區
  • 南美·中東·非洲

第9章 企業簡介

  • Fujifilm Holdings Corporation
  • Smith & Nephew PLC
  • Kolon TissueGene, Inc.
  • JCR Pharmaceuticals Co., Ltd.
  • Medipost Co., Ltd.
  • Stemedica Cell Technologies, Inc.
  • NuVasive, Inc.
  • Avantor, Inc.
  • Vericel Corporation
  • Pharmicell Co., Ltd.
目錄

The Global Cell Therapy Market size is expected to reach $28.5 billion by 2026, rising at a market growth of 26.2% CAGR during the forecast period. Cell therapy is considered as a technology that is based on substituting dysfunctional or diseased cells with active & functional cells. Stem cells possess the capability to differentiate into particular cells needed for repairing damaged or defective tissues or cells, that's why they are utilized for these advanced therapies. In addition, cell therapy is used in the development of regenerative medicines, which is an interdisciplinary domain aimed at maintenance, enhancement, or restoration of cell, tissue, organ function with the help of procedures majorly associated with cell therapy.

Moreover, cells like bone marrow and blood cells, mature, immature & solid tissue cells, adult stem cells, and embryonic cells are extensively deployed in cell therapy methods. Further, transplanted cells involve embryonic stem cells (ESCs), pluripotent stem cells (iPSCs), neural stem cells (NSCs), and mesenchymal stem cells (MSCs) are bifurcated mainly two groups viz. Allogeneic cell therapy and non-Allogeneic cell therapy.

At present, there are two types of cell therapies exist. The first type is cell therapy in mainstream medicine. This category includes human embryonic stem cell therapy, mesenchymal stem cell therapy, neural stem cell therapy, Autologous cell therapy, and hematopoietic stem cell therapy. The second category is in alternative medicine and perpetuates the practice of injecting animal materials in an effort to cure diseases. This practice, as per the American Cancer Society, is not supported by any medical proof of efficiency and can have fatal results.

The outbreak of the COVID-19 pandemic has affected many biopharmaceutical units, while many cellular therapy development organizations have observed a severe impact, which is due to the complexities in logistics and manufacturing models used in this sector. Moreover, considerable and constant investment is essential to allow effective commercial translation of cell-based therapeutics, an aspect that was negatively affected in 2020, further affected the overall market growth.

Therapy Type Outlook

Based on Therapy Type, the market is segmented into Autologous and Allogeneic. The Autologous therapies segment would show gradual growth due to the massive cost associated with Autologous transplants and comparatively less relapse rates. Though, development in cell banking and companies' switch towards the creation of allogenic therapy products is boosting the cell therapy market.

Therapeutic Area Outlook

Based on Therapeutic Area, the market is segmented into Malignancies, Autoimmune Disorders, Musculoskeletal Disorders, Dermatology and Others. The Malignancies market dominated the Global Cell Therapy Market by Therapeutic Area 2019, growing at a CAGR of 25.2 % during the forecast period. The Autoimmune Disorders market is experiencing a CAGR of 27.6% during (2020 - 2026). Additionally, The Musculoskeletal Disorders market would showcase a CAGR of 27.2% during (2020 - 2026).

End User Outlook

Based on End User, the market is segmented into Academic & Research Institutes and Hospitals & Clinics. In 2019, the Academic & Research Institutes segment emerged as the leading segment of the market and held the highest revenue share. The stem cells are significantly being utilized for research projects, which as a result, has contributed to a massive revenue share for the Academic & Research Institutes segment. The segment would show a similar trend during the forecast period.

Cell Type Outlook

Based on Cell Type, the market is segmented into Stem Cell, Umbilical Cord-Derived, Adipose-Derived Stem Cell, Non-Stem Cell, Bone Marrow, Blood and Others. The Stem Cell market dominated the Global Cell Therapy Market by Cell Type 2019, and would continue to be a dominant market till 2026. The Umbilical Cord-Derived market is expected to witness a CAGR of 27.7% during (2020 - 2026).

Regional Outlook

Based on Regions, the market is segmented into North America, Europe, Asia Pacific, and Latin America, Middle East & Africa. In 2019, North America emerged as the leading region of the global cell therapy market by obtaining the highest revenue share. The larger share of the region is due to the existence of a considerable number of centers and institutes that are undergoing R&D activities to stem cell therapy. Among the top universities in the world, 5 are based in the U.S., including Institute for Stem Cell Biology and Regenerative Medicine, Stanford University, Harvard Stem Cell Institute, Harvard University, and Yale Stem Cell Center.

The major strategies followed by the market participants are Partnerships. Based on the Analysis presented in the Cardinal matrix; Fujifilm Holdings Corporation is the major forerunner in the Cell Therapy Market. Companies such as JCR Pharmaceuticals Co., Ltd., NuVasive, Inc., Medipost Co., Ltd., Vericel Corporation, and Avantor, Inc. are some of the key innovators in the market.

The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Fujifilm Holdings Corporation, Smith & Nephew PLC, Kolon TissueGene, Inc., JCR Pharmaceuticals Co., Ltd., Medipost Co., Ltd., Stemedica Cell Technologies, Inc., NuVasive, Inc., Avantor, Inc., Vericel Corporation, and Pharmicell Co., Ltd.

Recent strategies deployed in Cell Therapy Market

Partnerships, Collaborations, and Agreements:

Mar-2021: Fujifilm collaborated with Sana Biotechnology, a biotechnology company. Under this collaboration, Sana has permitted a non-exclusive right to utilize the Fujifilm Cellular Dynamics' iPSC platform for the development of commercial cell therapies. Cell therapies as a treatment modality can boost, repair, or replace human biology that includes tissues, organs, and cells.

Nov-2020: Fujifilm came into partnership with Lonza Walkersville, a leading global GMP iPSC manufacturer. In this partnership, Fujifilm Cellular Dynamics permitted Lonza a non-exclusive right to utilize their patents related to iPSC generation, which include episomal vectors and reprogramming factors, for the clinical production and differentiation of iPSC lines for cell therapies.

Apr-2020: Fujifilm Diosynth Biotechnologies (FDB) entered into a partnership with OXGENE, an industry leader in the design and development of gene therapy technologies. The partnership enables FDB to provide gene therapy products to customers with an approximate 25% lead-time reduction.

Jun-2019: JCR Pharmaceuticals extended the partnership with Mesoblast Limited, an Australian-based regenerative medicine company. This expansion aimed to utilize mesenchymal stem cells (MSCs) for curing newborns who have insufficient blood supply and oxygen to the brain, this condition is termed neonatal hypoxic-ischemic encephalopathy (HIE).

Jan-019: Medipost signed a cooperation agreement with LG Chem, the largest Korean chemical company. In this agreement, both companies conducted research to discover a stem cell drug candidate for the next two years. Medipost would be responsible for making and delivering umbilical cord blood-derived mesenchymal stem cells and LG Chem has taken charge in choosing the genes, which cause disease and stem cell generation utilizing the genetic engineering techniques

Acquisition and Mergers:

Apr-2020: JCR Pharmaceuticals acquired ArmaGen, Inc., a privately-held US biopharmaceutical company. This acquisition is a testament to the company's robust commitment to bring advanced medicines to patients with mucopolysaccharidoses and other LSDs.

Mar-2019: Smith & Nephew came into agreement to acquire Osiris Therapeutics, a fast-growing company delivering regenerative medicine products. This acquisition will improve Smith & Nephew's portfolio and help instantly boost their wound management business and also offer longer-term innovations in additional channels and indications.

Product Launches and Product Expansions:

Sep-2020: Smith & Nephew introduced the HEALICOIL KNOTLESS Suture Anchor. This launch expanded its revolutionary portfolio of Advanced Healing Solutions for rotator cuff repair. This line of a product consists of the innovative REGENETEN Bioinductive Implant and novel REGENESORB Material. These are developed to support a jump start in bone healing and formation.

Mar-2020: Avantor Performance Materials introduced a new recombinant Protein A affinity chromatography resin. It is a proven downstream purification step in producing mAbs. This new Avantor recombinant protein A resin helps in coping up with these challenges.

Jul-2019: NuVasive introduced its Pulse platform. This platform integrated various technologies into multiple spine surgery procedures, which include corrections, bone fusions, and more. The modular workflow product line encompasses surgical planning, patient-specific rod bending, and 2D and 3D imaging and also alignment, navigation, neurological monitoring, and radiation reduction at the time of operation.

Jan-2019: Fujifilm Cellular Dynamics unveiled iCell Microglia. It is the immune cells of the central nervous system helps in fundamental physiological and pathological processes. The iCell Microglia is different from human iPSCs is utilized in life science research to allow the study and development of therapies for degenerative neurological diseases like Alzheimer's disease.

Geographical Expansions:

Jun-2020: Avantor expanded its Bridgewater, N.J. (USA) innovation center. This expansion improved the Company's R&D support for a personalized product and bioprocess development, and custom cell & gene therapy reagent production to support the customers' therapeutic products, which are developed for improvements in customized medicines.

Dec-2019: Avantor expanded its global presence by opening an innovation and customer support center in Shanghai, China. This center supports biopharma research and technology development in the region. With this expansion, Avantor has nine innovation centers across the globe. The new Avantor laboratory helps the biopharmaceutical companies to escalate the development of life-changing treatments for patients in the region.

Jan-2019: Fujifilm Cellular Dynamics, a US subsidiary of Fujifilm Corporation expanded its geographical footprints by establishing a new cGMP-compliant production facility. This expansion aimed to improve its production of iPS cells for cell therapy.

Scope of the Study

Market Segments covered in the Report:

By Therapy Type

  • Autologous
  • Allogeneic

By Therapeutic Area

  • Malignancies
  • Autoimmune Disorders
  • Musculoskeletal Disorders
  • Dermatology
  • Others

By End User

  • Academic & Research Institutes
  • Hospitals & Clinics

By Cell Type

  • Stem Cell
  • Umbilical Cord-Derived
  • Adipose-Derived Stem Cell
  • Non-Stem Cell
  • Bone Marrow
  • Blood
  • Others

By Geography

  • North America

US

Canada

Mexico

Rest of North America

  • Europe

Germany

UK

France

Russia

Spain

Italy

Rest of Europe

  • Asia Pacific

China

Japan

India

South Korea

Singapore

Malaysia

Rest of Asia Pacific

  • LAMEA

Brazil

Argentina

UAE

Saudi Arabia

South Africa

Nigeria

Rest of LAMEA

Companies Profiled

  • Fujifilm Holdings Corporation
  • Smith & Nephew PLC
  • Kolon TissueGene, Inc.
  • JCR Pharmaceuticals Co., Ltd.
  • Medipost Co., Ltd.
  • Stemedica Cell Technologies, Inc.
  • NuVasive, Inc.
  • Avantor, Inc.
  • Vericel Corporation
  • Pharmicell Co., Ltd.

Unique Offerings from KBV Research

  • Exhaustive coverage
  • Highest number of market tables and figures
  • Subscription based model available
  • Guaranteed best price
  • Assured post sales research support with 10% customization free

Table of Contents

Chapter 1. Market Scope & Methodology

  • 1.1 Market Definition
  • 1.2 Objectives
  • 1.3 Market Scope
  • 1.4 Segmentation
    • 1.4.1 Global Cell Therapy Market, by Therapy Type
    • 1.4.2 Global Cell Therapy Market, by Therapeutic Area
    • 1.4.3 Global Cell Therapy Market, by End User
    • 1.4.4 Global Cell Therapy Market, by Cell Type
    • 1.4.5 Global Cell Therapy Market, by Geography
  • 1.5 Methodology for the research

Chapter 2. Market Overview

  • 2.1 Introduction
    • 2.1.1 Overview
    • 2.1.2 Market Composition and Scenario
  • 2.2 Key Factors Impacting the Market
    • 2.2.1 Market Drivers
    • 2.2.2 Market Restraints

Chapter 3. Competition Analysis - Global

  • 3.1 KBV Cardinal Matrix
  • 3.2 Recent Industry Wide Strategic Developments
    • 3.2.1 Partnerships, Collaborations and Agreements
    • 3.2.2 Product Launches and Product Expansions
    • 3.2.3 Geographical Expansions
    • 3.2.4 Approvals & Trials
    • 3.2.5 Acquisition and Mergers
  • 3.3 Top Winning Strategies
    • 3.3.1 Key Leading Strategies: Percentage Distribution (2016-2020)

Chapter 4. Global Cell Therapy Market by Therapy Type

  • 4.1 Global Autologous Market by Region
  • 4.2 Global Allogeneic Market by Region

Chapter 5. Global Cell Therapy Market by Therapeutic Area

  • 5.1 Global Malignancies Market by Region
  • 5.2 Global Autoimmune Disorders Market by Region
  • 5.3 Global Musculoskeletal Disorders Market by Region
  • 5.4 Global Dermatology Market by Region
  • 5.5 Global Other Therapeutic Area Market by Region

Chapter 6. Global Cell Therapy Market by End User

  • 6.1 Global Academic & Research Institutes Market by Region
  • 6.2 Global Hospitals & Clinics Market by Region

Chapter 7. Global Cell Therapy Market by Cell Type

  • 7.1 Global Stem Cell Market by Region
  • 7.2 Global Umbilical Cord-Derived Cell Market by Region
  • 7.3 Global Adipose-Derived Stem Cell Market by Region
  • 7.4 Global Non-Stem Cell Market by Region
  • 7.5 Global Bone Marrow Cell Market by Region
  • 7.6 Global Blood Cell Market by Region
  • 7.7 Global Others Cell Market by Region

Chapter 8. Global Cell Therapy Market by Region

  • 8.1 North America Cell Therapy Market
    • 8.1.1 North America Cell Therapy Market by Therapy Type
      • 8.1.1.1 North America Autologous Market by Country
      • 8.1.1.2 North America Allogeneic Market by Country
    • 8.1.2 North America Cell Therapy Market by Therapeutic Area
      • 8.1.2.1 North America Malignancies Market by Country
      • 8.1.2.2 North America Autoimmune Disorders Market by Country
      • 8.1.2.3 North America Musculoskeletal Disorders Market by Country
      • 8.1.2.4 North America Dermatology Market by Country
      • 8.1.2.5 North America Other Therapeutic Area Market by Country
    • 8.1.3 North America Cell Therapy Market by Therapy Type
      • 8.1.3.1 North America Academic & Research Institutes Market by Country
      • 8.1.3.2 North America Hospitals & Clinics Market by Country
    • 8.1.4 North America Cell Therapy Market by Cell Type
      • 8.1.4.1 North America Stem Cell Market by Country
      • 8.1.4.2 North America Umbilical Cord-Derived Cell Market by Country
      • 8.1.4.3 North America Adipose-Derived Stem Cell Market by Country
      • 8.1.4.4 North America Non-Stem Cell Market by Country
      • 8.1.4.5 North America Bone Marrow Cell Market by Country
      • 8.1.4.6 North America Blood Cell Market by Country
      • 8.1.4.7 North America Others Cell Market by Country
    • 8.1.5 North America Cell Therapy Market by Country
      • 8.1.5.1 US Cell Therapy Market
        • 8.1.5.1.1 US Cell Therapy Market by Therapy Type
        • 8.1.5.1.2 US Cell Therapy Market by Therapeutic Area
        • 8.1.5.1.3 US Cell Therapy Market by End User
        • 8.1.5.1.4 US Cell Therapy Market by Cell Type
      • 8.1.5.2 Canada Cell Therapy Market
        • 8.1.5.2.1 Canada Cell Therapy Market by Therapy Type
        • 8.1.5.2.2 Canada Cell Therapy Market by Therapeutic Area
        • 8.1.5.2.3 Canada Cell Therapy Market by End User
        • 8.1.5.2.4 Canada Cell Therapy Market by Cell Type
      • 8.1.5.3 Mexico Cell Therapy Market
        • 8.1.5.3.1 Mexico Cell Therapy Market by Therapy Type
        • 8.1.5.3.2 Mexico Cell Therapy Market by Therapeutic Area
        • 8.1.5.3.3 Mexico Cell Therapy Market by End User
        • 8.1.5.3.4 Mexico Cell Therapy Market by Cell Type
      • 8.1.5.4 Rest of North America Cell Therapy Market
        • 8.1.5.4.1 Rest of North America Cell Therapy Market by Therapy Type
        • 8.1.5.4.2 Rest of North America Cell Therapy Market by Therapeutic Area
        • 8.1.5.4.3 Rest of North America Cell Therapy Market by End User
        • 8.1.5.4.4 Rest of North America Cell Therapy Market by Cell Type
  • 8.2 Europe Cell Therapy Market
    • 8.2.1 Europe Cell Therapy Market by Therapy Type
      • 8.2.1.1 Europe Autologous Market by Country
      • 8.2.1.2 Europe Allogeneic Market by Country
    • 8.2.2 Europe Cell Therapy Market by Therapeutic Area
      • 8.2.2.1 Europe Malignancies Market by Country
      • 8.2.2.2 Europe Autoimmune Disorders Market by Country
      • 8.2.2.3 Europe Musculoskeletal Disorders Market by Country
      • 8.2.2.4 Europe Dermatology Market by Country
      • 8.2.2.5 Europe Other Therapeutic Area Market by Country
    • 8.2.3 Europe Cell Therapy Market by End User
      • 8.2.3.1 Europe Academic & Research Institutes Market by Country
      • 8.2.3.2 Europe Hospitals & Clinics Market by Country
    • 8.2.4 Europe Cell Therapy Market by Cell Type
      • 8.2.4.1 Europe Stem Cell Market by Country
      • 8.2.4.2 Europe Umbilical Cord-Derived Cell Market by Country
      • 8.2.4.3 Europe Adipose-Derived Stem Cell Market by Country
      • 8.2.4.4 Europe Non-Stem Cell Market by Country
      • 8.2.4.5 Europe Bone Marrow Cell Market by Country
      • 8.2.4.6 Europe Blood Cell Market by Country
      • 8.2.4.7 Europe Others Cell Market by Country
    • 8.2.5 Europe Cell Therapy Market by Country
      • 8.2.5.1 Germany Cell Therapy Market
        • 8.2.5.1.1 Germany Cell Therapy Market by Therapy Type
        • 8.2.5.1.2 Germany Cell Therapy Market by Therapeutic Area
        • 8.2.5.1.3 Germany Cell Therapy Market by End User
        • 8.2.5.1.4 Germany Cell Therapy Market by Cell Type
      • 8.2.5.2 UK Cell Therapy Market
        • 8.2.5.2.1 UK Cell Therapy Market by Therapy Type
        • 8.2.5.2.2 UK Cell Therapy Market by Therapeutic Area
        • 8.2.5.2.3 UK Cell Therapy Market by End User
        • 8.2.5.2.4 UK Cell Therapy Market by Cell Type
      • 8.2.5.3 France Cell Therapy Market
        • 8.2.5.3.1 France Cell Therapy Market by Therapy Type
        • 8.2.5.3.2 France Cell Therapy Market by Therapeutic Area
        • 8.2.5.3.3 France Cell Therapy Market by End User
        • 8.2.5.3.4 France Cell Therapy Market by Cell Type
      • 8.2.5.4 Russia Cell Therapy Market
        • 8.2.5.4.1 Russia Cell Therapy Market by Therapy Type
        • 8.2.5.4.2 Russia Cell Therapy Market by Therapeutic Area
        • 8.2.5.4.3 Russia Cell Therapy Market by End User
        • 8.2.5.4.4 Russia Cell Therapy Market by Cell Type
      • 8.2.5.5 Spain Cell Therapy Market
        • 8.2.5.5.1 Spain Cell Therapy Market by Therapy Type
        • 8.2.5.5.2 Spain Cell Therapy Market by Therapeutic Area
        • 8.2.5.5.3 Spain Cell Therapy Market by End User
        • 8.2.5.5.4 Spain Cell Therapy Market by Cell Type
      • 8.2.5.6 Italy Cell Therapy Market
        • 8.2.5.6.1 Italy Cell Therapy Market by Therapy Type
        • 8.2.5.6.2 Italy Cell Therapy Market by Therapeutic Area
        • 8.2.5.6.3 Italy Cell Therapy Market by End User
        • 8.2.5.6.4 Italy Cell Therapy Market by Cell Type
      • 8.2.5.7 Rest of Europe Cell Therapy Market
        • 8.2.5.7.1 Rest of Europe Cell Therapy Market by Therapy Type
        • 8.2.5.7.2 Rest of Europe Cell Therapy Market by Therapeutic Area
        • 8.2.5.7.3 Rest of Europe Cell Therapy Market by End User
        • 8.2.5.7.4 Rest of Europe Cell Therapy Market by Cell Type
  • 8.3 Asia Pacific Cell Therapy Market
    • 8.3.1 Asia Pacific Cell Therapy Market by Therapy Type
      • 8.3.1.1 Asia Pacific Autologous Market by Country
      • 8.3.1.2 Asia Pacific Allogeneic Market by Country
    • 8.3.2 Asia Pacific Cell Therapy Market by Therapeutic Area
      • 8.3.2.1 Asia Pacific Malignancies Market by Country
      • 8.3.2.2 Asia Pacific Autoimmune Disorders Market by Country
      • 8.3.2.3 Asia Pacific Musculoskeletal Disorders Market by Country
      • 8.3.2.4 Asia Pacific Dermatology Market by Country
      • 8.3.2.5 Asia Pacific Other Therapeutic Area Market by Country
    • 8.3.3 Asia Pacific Cell Therapy Market by End User
      • 8.3.3.1 Asia Pacific Academic & Research Institutes Market by Country
      • 8.3.3.2 Asia Pacific Hospitals & Clinics Market by Country
    • 8.3.4 Asia Pacific Cell Therapy Market by Cell Type
      • 8.3.4.1 Asia Pacific Stem Cell Market by Country
      • 8.3.4.2 Asia Pacific Umbilical Cord-Derived Cell Market by Country
      • 8.3.4.3 Asia Pacific Adipose-Derived Stem Cell Market by Country
      • 8.3.4.4 Asia Pacific Non-Stem Cell Market by Country
      • 8.3.4.5 Asia Pacific Bone Marrow Cell Market by Country
      • 8.3.4.6 Asia Pacific Blood Cell Market by Country
      • 8.3.4.7 Asia Pacific Others Cell Market by Country
    • 8.3.5 Asia Pacific Cell Therapy Market by Country
      • 8.3.5.1 China Cell Therapy Market
        • 8.3.5.1.1 China Cell Therapy Market by Therapy Type
        • 8.3.5.1.2 China Cell Therapy Market by Therapeutic Area
        • 8.3.5.1.3 China Cell Therapy Market by End User
        • 8.3.5.1.4 China Cell Therapy Market by Cell Type
      • 8.3.5.2 Japan Cell Therapy Market
        • 8.3.5.2.1 Japan Cell Therapy Market by Therapy Type
        • 8.3.5.2.2 Japan Cell Therapy Market by Therapeutic Area
        • 8.3.5.2.3 Japan Cell Therapy Market by End User
        • 8.3.5.2.4 Japan Cell Therapy Market by Cell Type
      • 8.3.5.3 India Cell Therapy Market
        • 8.3.5.3.1 India Cell Therapy Market by Therapy Type
        • 8.3.5.3.2 India Cell Therapy Market by Therapeutic Area
        • 8.3.5.3.3 India Cell Therapy Market by End User
        • 8.3.5.3.4 India Cell Therapy Market by Cell Type
      • 8.3.5.4 South Korea Cell Therapy Market
        • 8.3.5.4.1 South Korea Cell Therapy Market by Therapy Type
        • 8.3.5.4.2 South Korea Cell Therapy Market by Therapeutic Area
        • 8.3.5.4.3 South Korea Cell Therapy Market by End User
        • 8.3.5.4.4 South Korea Cell Therapy Market by Cell Type
      • 8.3.5.5 Singapore Cell Therapy Market
        • 8.3.5.5.1 Singapore Cell Therapy Market by Therapy Type
        • 8.3.5.5.2 Singapore Cell Therapy Market by Therapeutic Area
        • 8.3.5.5.3 Singapore Cell Therapy Market by End User
        • 8.3.5.5.4 Singapore Cell Therapy Market by Cell Type
      • 8.3.5.6 Malaysia Cell Therapy Market
        • 8.3.5.6.1 Malaysia Cell Therapy Market by Therapy Type
        • 8.3.5.6.2 Malaysia Cell Therapy Market by Therapeutic Area
        • 8.3.5.6.3 Malaysia Cell Therapy Market by End User
        • 8.3.5.6.4 Malaysia Cell Therapy Market by Cell Type
      • 8.3.5.7 Rest of Asia Pacific Cell Therapy Market
        • 8.3.5.7.1 Rest of Asia Pacific Cell Therapy Market by Therapy Type
        • 8.3.5.7.2 Rest of Asia Pacific Cell Therapy Market by Therapeutic Area
        • 8.3.5.7.3 Rest of Asia Pacific Cell Therapy Market by End User
        • 8.3.5.7.4 Rest of Asia Pacific Cell Therapy Market by Cell Type
  • 8.4 LAMEA Cell Therapy Market
    • 8.4.1 LAMEA Cell Therapy Market by Therapy Type
      • 8.4.1.1 LAMEA Autologous Market by Country
      • 8.4.1.2 LAMEA Allogeneic Market by Country
    • 8.4.2 LAMEA Cell Therapy Market by Therapeutic Area
      • 8.4.2.1 LAMEA Malignancies Market by Country
      • 8.4.2.2 LAMEA Autoimmune Disorders Market by Country
      • 8.4.2.3 LAMEA Musculoskeletal Disorders Market by Country
      • 8.4.2.4 LAMEA Dermatology Market by Country
      • 8.4.2.5 LAMEA Other Therapeutic Area Market by Country
    • 8.4.3 LAMEA Cell Therapy Market by End User
      • 8.4.3.1 LAMEA Academic & Research Institutes Market by Country
      • 8.4.3.2 LAMEA Hospitals & Clinics Market by Country
      • 8.4.3.3 LAMEA Cell Therapy Market by Cell Type
      • 8.4.3.4 LAMEA Stem Cell Market by Country
      • 8.4.3.5 LAMEA Umbilical Cord-Derived Cell Market by Country
      • 8.4.3.6 LAMEA Adipose-Derived Stem Cell Market by Country
      • 8.4.3.7 LAMEA Non-Stem Cell Market by Country
      • 8.4.3.8 LAMEA Bone Marrow Cell Market by Country
      • 8.4.3.9 LAMEA Blood Cell Market by Country
      • 8.4.3.10 LAMEA Others Cell Market by Country
    • 8.4.4 LAMEA Cell Therapy Market by Country
      • 8.4.4.1 Brazil Cell Therapy Market
        • 8.4.4.1.1 Brazil Cell Therapy Market by Therapy Type
        • 8.4.4.1.2 Brazil Cell Therapy Market by Therapeutic Area
        • 8.4.4.1.3 Brazil Cell Therapy Market by End User
        • 8.4.4.1.4 Brazil Cell Therapy Market by Cell Type
      • 8.4.4.2 Argentina Cell Therapy Market
        • 8.4.4.2.1 Argentina Cell Therapy Market by Therapy Type
        • 8.4.4.2.2 Argentina Cell Therapy Market by Therapeutic Area
        • 8.4.4.2.3 Argentina Cell Therapy Market by End User
        • 8.4.4.2.4 Argentina Cell Therapy Market by Cell Type
      • 8.4.4.3 UAE Cell Therapy Market
        • 8.4.4.3.1 UAE Cell Therapy Market by Therapy Type
        • 8.4.4.3.2 UAE Cell Therapy Market by Therapeutic Area
        • 8.4.4.3.3 UAE Cell Therapy Market by End User
        • 8.4.4.3.4 UAE Cell Therapy Market by Cell Type
      • 8.4.4.4 Saudi Arabia Cell Therapy Market
        • 8.4.4.4.1 Saudi Arabia Cell Therapy Market by Therapy Type
        • 8.4.4.4.2 Saudi Arabia Cell Therapy Market by Therapeutic Area
        • 8.4.4.4.3 Saudi Arabia Cell Therapy Market by End User
        • 8.4.4.4.4 Saudi Arabia Cell Therapy Market by Cell Type
      • 8.4.4.5 South Africa Cell Therapy Market
        • 8.4.4.5.1 South Africa Cell Therapy Market by Therapy Type
        • 8.4.4.5.2 South Africa Cell Therapy Market by Therapeutic Area
        • 8.4.4.5.3 South Africa Cell Therapy Market by End User
        • 8.4.4.5.4 South Africa Cell Therapy Market by Cell Type
      • 8.4.4.6 Nigeria Cell Therapy Market
        • 8.4.4.6.1 Nigeria Cell Therapy Market by Therapy Type
        • 8.4.4.6.2 Nigeria Cell Therapy Market by Therapeutic Area
        • 8.4.4.6.3 Nigeria Cell Therapy Market by End User
        • 8.4.4.6.4 Nigeria Cell Therapy Market by Cell Type
      • 8.4.4.7 Rest of LAMEA Cell Therapy Market
        • 8.4.4.7.1 Rest of LAMEA Cell Therapy Market by Therapy Type
        • 8.4.4.7.2 Rest of LAMEA Cell Therapy Market by Therapeutic Area
        • 8.4.4.7.3 Rest of LAMEA Cell Therapy Market by End User
        • 8.4.4.7.4 Rest of LAMEA Cell Therapy Market by Cell Type

Chapter 9. Company Profiles

  • 9.1 Fujifilm Holdings Corporation
    • 9.1.1 Company Overview
    • 9.1.2 Financial Analysis
    • 9.1.3 Segmental and Regional Analysis
    • 9.1.4 Research & Development Expense
    • 9.1.5 Recent strategies and developments:
      • 9.1.5.1 Partnerships, Collaborations, and Agreements:
      • 9.1.5.2 Product Launches and Product Expansions:
      • 9.1.5.3 Geographical Expansions:
  • 9.2 Smith & Nephew PLC
    • 9.2.1 Company Overview
    • 9.2.2 Financial Analysis
    • 9.2.3 Segmental and Regional Analysis
    • 9.2.4 Research & Development Expense
    • 9.2.5 Recent strategies and developments:
      • 9.2.5.1 Product Launches and Product Expansions:
      • 9.2.5.2 Acquisition and Mergers:
  • 9.3 Kolon TissueGene, Inc.
    • 9.3.1 Company Overview
    • 9.3.2 Recent strategies and developments:
      • 9.3.2.1 Approvals & Trials:
  • 9.4 JCR Pharmaceuticals Co., Ltd.
    • 9.4.1 Company Overview
    • 9.4.2 Financial Analysis
    • 9.4.3 Research & Development Expense
    • 9.4.4 Recent strategies and developments:
      • 9.4.4.1 Partnerships, Collaborations, and Agreements:
      • 9.4.4.2 Acquisition and Mergers:
      • 9.4.4.3 Approvals & Trials:
  • 9.5 Medipost Co., Ltd.
    • 9.5.1 Company Overview
    • 9.5.2 Financial Analysis
    • 9.5.3 Recent strategies and developments:
      • 9.5.3.1 Partnerships, Collaborations, and Agreements:
      • 9.5.3.2 Approvals & Trials:
  • 9.6 Stemedica Cell Technologies, Inc.
    • 9.6.1 Company Overview
    • 9.6.2 Recent strategies and developments:
      • 9.6.2.1 Approvals & Trials:
  • 9.7 NuVasive, Inc.
    • 9.7.1 Company Overview
    • 9.7.2 Financial Analysis
    • 9.7.3 Regional Analysis
    • 9.7.4 Research & Development Expense
    • 9.7.5 Recent strategies and developments:
      • 9.7.5.1 Product Launches and Product Expansions:
  • 9.8 Avantor, Inc.
    • 9.8.1 Company Overview
    • 9.8.2 Financial Analysis
    • 9.8.3 Regional Analysis
    • 9.8.4 Recent strategies and developments:
      • 9.8.4.1 Product Launches and Product Expansions:
      • 9.8.4.2 Geographical Expansions:
  • 9.9 Vericel Corporation
    • 9.9.1 Company Overview
    • 9.9.2 Financial Analysis
    • 9.9.3 Research & Development Expense
    • 9.9.4 Recent strategies and developments:
      • 9.9.4.1 Partnerships, Collaborations, and Agreements:
      • 9.9.4.2 Product Launches and Product Expansions:
  • 9.1 Pharmicell Co., Ltd.
    • 9.10.1 Company Overview
    • 9.10.2 Financial Analysis
    • 9.10.3 Research & Development Expense
    • 9.10.4 Recent strategies and developments:
      • 9.10.4.1 Partnerships, Collaborations, and Agreements:

LIST OF TABLES

  • TABLE 1 Global Cell Therapy Market, 2016 - 2019, USD Million
  • TABLE 2 Global Cell Therapy Market, 2020 - 2026, USD Million
  • TABLE 3 Partnerships, Collaborations and Agreements- Cell Therapy Market
  • TABLE 4 Product Launches And Product Expansions- Cell Therapy Market
  • TABLE 5 Geographical Expansions- Cell Therapy Market
  • TABLE 6 Approvals & Trials- Cell Therapy Market
  • TABLE 7 Acquisition and Mergers- Cell Therapy Market
  • TABLE 8 Global Cell Therapy Market by Therapy Type, 2016 - 2019, USD Million
  • TABLE 9 Global Cell Therapy Market by Therapy Type, 2020 - 2026, USD Million
  • TABLE 10 Global Autologous Market by Region, 2016 - 2019, USD Million
  • TABLE 11 Global Autologous Market by Region, 2020 - 2026, USD Million
  • TABLE 12 Global Allogeneic Market by Region, 2016 - 2019, USD Million
  • TABLE 13 Global Allogeneic Market by Region, 2020 - 2026, USD Million
  • TABLE 14 Global Cell Therapy Market by Therapeutic Area, 2016 - 2019, USD Million
  • TABLE 15 Global Cell Therapy Market by Therapeutic Area, 2020 - 2026, USD Million
  • TABLE 16 Global Malignancies Market by Region, 2016 - 2019, USD Million
  • TABLE 17 Global Malignancies Market by Region, 2020 - 2026, USD Million
  • TABLE 18 Global Autoimmune Disorders Market by Region, 2016 - 2019, USD Million
  • TABLE 19 Global Autoimmune Disorders Market by Region, 2020 - 2026, USD Million
  • TABLE 20 Global Musculoskeletal Disorders Market by Region, 2016 - 2019, USD Million
  • TABLE 21 Global Musculoskeletal Disorders Market by Region, 2020 - 2026, USD Million
  • TABLE 22 Global Dermatology Market by Region, 2016 - 2019, USD Million
  • TABLE 23 Global Dermatology Market by Region, 2020 - 2026, USD Million
  • TABLE 24 Global Other Therapeutic Area Market by Region, 2016 - 2019, USD Million
  • TABLE 25 Global Other Therapeutic Area Market by Region, 2020 - 2026, USD Million
  • TABLE 26 Global Cell Therapy Market by End User, 2016 - 2019, USD Million
  • TABLE 27 Global Cell Therapy Market by End User, 2020 - 2026, USD Million
  • TABLE 28 Global Academic & Research Institutes Market by Region, 2016 - 2019, USD Million
  • TABLE 29 Global Academic & Research Institutes Market by Region, 2020 - 2026, USD Million
  • TABLE 30 Global Hospitals & Clinics Market by Region, 2016 - 2019, USD Million
  • TABLE 31 Global Hospitals & Clinics Market by Region, 2020 - 2026, USD Million
  • TABLE 32 Global Cell Therapy Market by Cell Type, 2016 - 2019, USD Million
  • TABLE 33 Global Cell Therapy Market by Cell Type, 2020 - 2026, USD Million
  • TABLE 34 Global Stem Cell Market by Region, 2016 - 2019, USD Million
  • TABLE 35 Global Stem Cell Market by Region, 2020 - 2026, USD Million
  • TABLE 36 Global Umbilical Cord-Derived Cell Market by Region, 2016 - 2019, USD Million
  • TABLE 37 Global Umbilical Cord-Derived Cell Market by Region, 2020 - 2026, USD Million
  • TABLE 38 Global Adipose-Derived Stem Cell Market by Region, 2016 - 2019, USD Million
  • TABLE 39 Global Adipose-Derived Stem Cell Market by Region, 2020 - 2026, USD Million
  • TABLE 40 Global Non-Stem Cell Market by Region, 2016 - 2019, USD Million
  • TABLE 41 Global Non-Stem Cell Market by Region, 2020 - 2026, USD Million
  • TABLE 42 Global Bone Marrow Cell Market by Region, 2016 - 2019, USD Million
  • TABLE 43 Global Bone Marrow Cell Market by Region, 2020 - 2026, USD Million
  • TABLE 44 Global Blood Cell Market by Region, 2016 - 2019, USD Million
  • TABLE 45 Global Blood Cell Market by Region, 2020 - 2026, USD Million
  • TABLE 46 Global Others Cell Market by Region, 2016 - 2019, USD Million
  • TABLE 47 Global Others Cell Market by Region, 2020 - 2026, USD Million
  • TABLE 48 Global Cell Therapy Market by Region, 2016 - 2019, USD Million
  • TABLE 49 Global Cell Therapy Market by Region, 2020 - 2026, USD Million
  • TABLE 50 North America Cell Therapy Market, 2016 - 2019, USD Million
  • TABLE 51 North America Cell Therapy Market, 2020 - 2026, USD Million
  • TABLE 52 North America Cell Therapy Market by Therapy Type, 2016 - 2019, USD Million
  • TABLE 53 North America Cell Therapy Market by Therapy Type, 2020 - 2026, USD Million
  • TABLE 54 North America Autologous Market by Country, 2016 - 2019, USD Million
  • TABLE 55 North America Autologous Market by Country, 2020 - 2026, USD Million
  • TABLE 56 North America Allogeneic Market by Country, 2016 - 2019, USD Million
  • TABLE 57 North America Allogeneic Market by Country, 2020 - 2026, USD Million
  • TABLE 58 North America Cell Therapy Market by Therapeutic Area, 2016 - 2019, USD Million
  • TABLE 59 North America Cell Therapy Market by Therapeutic Area, 2020 - 2026, USD Million
  • TABLE 60 North America Malignancies Market by Country, 2016 - 2019, USD Million
  • TABLE 61 North America Malignancies Market by Country, 2020 - 2026, USD Million
  • TABLE 62 North America Autoimmune Disorders Market by Country, 2016 - 2019, USD Million
  • TABLE 63 North America Autoimmune Disorders Market by Country, 2020 - 2026, USD Million
  • TABLE 64 North America Musculoskeletal Disorders Market by Country, 2016 - 2019, USD Million
  • TABLE 65 North America Musculoskeletal Disorders Market by Country, 2020 - 2026, USD Million
  • TABLE 66 North America Dermatology Market by Country, 2016 - 2019, USD Million
  • TABLE 67 North America Dermatology Market by Country, 2020 - 2026, USD Million
  • TABLE 68 North America Other Therapeutic Area Market by Country, 2016 - 2019, USD Million
  • TABLE 69 North America Other Therapeutic Area Market by Country, 2020 - 2026, USD Million
  • TABLE 70 North America Cell Therapy Market by Therapy Type, 2016 - 2019, USD Million
  • TABLE 71 North America Cell Therapy Market by Therapy Type, 2020 - 2026, USD Million
  • TABLE 72 North America Academic & Research Institutes Market by Country, 2016 - 2019, USD Million
  • TABLE 73 North America Academic & Research Institutes Market by Country, 2020 - 2026, USD Million
  • TABLE 74 North America Hospitals & Clinics Market by Country, 2016 - 2019, USD Million
  • TABLE 75 North America Hospitals & Clinics Market by Country, 2020 - 2026, USD Million
  • TABLE 76 North America Cell Therapy Market by Cell Type, 2016 - 2019, USD Million
  • TABLE 77 North America Cell Therapy Market by Cell Type, 2020 - 2026, USD Million
  • TABLE 78 North America Stem Cell Market by Country, 2016 - 2019, USD Million
  • TABLE 79 North America Stem Cell Market by Country, 2020 - 2026, USD Million
  • TABLE 80 North America Umbilical Cord-Derived Cell Market by Country, 2016 - 2019, USD Million
  • TABLE 81 North America Umbilical Cord-Derived Cell Market by Country, 2020 - 2026, USD Million
  • TABLE 82 North America Adipose-Derived Stem Cell Market by Country, 2016 - 2019, USD Million
  • TABLE 83 North America Adipose-Derived Stem Cell Market by Country, 2020 - 2026, USD Million
  • TABLE 84 North America Non-Stem Cell Market by Country, 2016 - 2019, USD Million
  • TABLE 85 North America Non-Stem Cell Market by Country, 2020 - 2026, USD Million
  • TABLE 86 North America Bone Marrow Cell Market by Country, 2016 - 2019, USD Million
  • TABLE 87 North America Bone Marrow Cell Market by Country, 2020 - 2026, USD Million
  • TABLE 88 North America Blood Cell Market by Country, 2016 - 2019, USD Million
  • TABLE 89 North America Blood Cell Market by Country, 2020 - 2026, USD Million
  • TABLE 90 North America Others Cell Market by Country, 2016 - 2019, USD Million
  • TABLE 91 North America Others Cell Market by Country, 2020 - 2026, USD Million
  • TABLE 92 North America Cell Therapy Market by Country, 2016 - 2019, USD Million
  • TABLE 93 North America Cell Therapy Market by Country, 2020 - 2026, USD Million
  • TABLE 94 US Cell Therapy Market, 2016 - 2019, USD Million
  • TABLE 95 US Cell Therapy Market, 2020 - 2026, USD Million
  • TABLE 96 US Cell Therapy Market by Therapy Type, 2016 - 2019, USD Million
  • TABLE 97 US Cell Therapy Market by Therapy Type, 2020 - 2026, USD Million
  • TABLE 98 US Cell Therapy Market by Therapeutic Area, 2016 - 2019, USD Million
  • TABLE 99 US Cell Therapy Market by Therapeutic Area, 2020 - 2026, USD Million
  • TABLE 100 US Cell Therapy Market by End User, 2016 - 2019, USD Million
  • TABLE 101 US Cell Therapy Market by End User, 2020 - 2026, USD Million
  • TABLE 102 US Cell Therapy Market by Cell Type, 2016 - 2019, USD Million
  • TABLE 103 US Cell Therapy Market by Cell Type, 2020 - 2026, USD Million
  • TABLE 104 Canada Cell Therapy Market, 2016 - 2019, USD Million
  • TABLE 105 Canada Cell Therapy Market, 2020 - 2026, USD Million
  • TABLE 106 Canada Cell Therapy Market by Therapy Type, 2016 - 2019, USD Million
  • TABLE 107 Canada Cell Therapy Market by Therapy Type, 2020 - 2026, USD Million
  • TABLE 108 Canada Cell Therapy Market by Therapeutic Area, 2016 - 2019, USD Million
  • TABLE 109 Canada Cell Therapy Market by Therapeutic Area, 2020 - 2026, USD Million
  • TABLE 110 Canada Cell Therapy Market by End User, 2016 - 2019, USD Million
  • TABLE 111 Canada Cell Therapy Market by End User, 2020 - 2026, USD Million
  • TABLE 112 Canada Cell Therapy Market by Cell Type, 2016 - 2019, USD Million
  • TABLE 113 Canada Cell Therapy Market by Cell Type, 2020 - 2026, USD Million
  • TABLE 114 Mexico Cell Therapy Market, 2016 - 2019, USD Million
  • TABLE 115 Mexico Cell Therapy Market, 2020 - 2026, USD Million
  • TABLE 116 Mexico Cell Therapy Market by Therapy Type, 2016 - 2019, USD Million
  • TABLE 117 Mexico Cell Therapy Market by Therapy Type, 2020 - 2026, USD Million
  • TABLE 118 Mexico Cell Therapy Market by Therapeutic Area, 2016 - 2019, USD Million
  • TABLE 119 Mexico Cell Therapy Market by Therapeutic Area, 2020 - 2026, USD Million
  • TABLE 120 Mexico Cell Therapy Market by End User, 2016 - 2019, USD Million
  • TABLE 121 Mexico Cell Therapy Market by End User, 2020 - 2026, USD Million
  • TABLE 122 Mexico Cell Therapy Market by Cell Type, 2016 - 2019, USD Million
  • TABLE 123 Mexico Cell Therapy Market by Cell Type, 2020 - 2026, USD Million
  • TABLE 124 Rest of North America Cell Therapy Market, 2016 - 2019, USD Million
  • TABLE 125 Rest of North America Cell Therapy Market, 2020 - 2026, USD Million
  • TABLE 126 Rest of North America Cell Therapy Market by Therapy Type, 2016 - 2019, USD Million
  • TABLE 127 Rest of North America Cell Therapy Market by Therapy Type, 2020 - 2026, USD Million
  • TABLE 128 Rest of North America Cell Therapy Market by Therapeutic Area, 2016 - 2019, USD Million
  • TABLE 129 Rest of North America Cell Therapy Market by Therapeutic Area, 2020 - 2026, USD Million
  • TABLE 130 Rest of North America Cell Therapy Market by End User, 2016 - 2019, USD Million
  • TABLE 131 Rest of North America Cell Therapy Market by End User, 2020 - 2026, USD Million
  • TABLE 132 Rest of North America Cell Therapy Market by Cell Type, 2016 - 2019, USD Million
  • TABLE 133 Rest of North America Cell Therapy Market by Cell Type, 2020 - 2026, USD Million
  • TABLE 134 Europe Cell Therapy Market, 2016 - 2019, USD Million
  • TABLE 135 Europe Cell Therapy Market, 2020 - 2026, USD Million
  • TABLE 136 Europe Cell Therapy Market by Therapy Type, 2016 - 2019, USD Million
  • TABLE 137 Europe Cell Therapy Market by Therapy Type, 2020 - 2026, USD Million
  • TABLE 138 Europe Autologous Market by Country, 2016 - 2019, USD Million
  • TABLE 139 Europe Autologous Market by Country, 2020 - 2026, USD Million
  • TABLE 140 Europe Allogeneic Market by Country, 2016 - 2019, USD Million
  • TABLE 141 Europe Allogeneic Market by Country, 2020 - 2026, USD Million
  • TABLE 142 Europe Cell Therapy Market by Therapeutic Area, 2016 - 2019, USD Million
  • TABLE 143 Europe Cell Therapy Market by Therapeutic Area, 2020 - 2026, USD Million
  • TABLE 144 Europe Malignancies Market by Country, 2016 - 2019, USD Million
  • TABLE 145 Europe Malignancies Market by Country, 2020 - 2026, USD Million
  • TABLE 146 Europe Autoimmune Disorders Market by Country, 2016 - 2019, USD Million
  • TABLE 147 Europe Autoimmune Disorders Market by Country, 2020 - 2026, USD Million
  • TABLE 148 Europe Musculoskeletal Disorders Market by Country, 2016 - 2019, USD Million
  • TABLE 149 Europe Musculoskeletal Disorders Market by Country, 2020 - 2026, USD Million
  • TABLE 150 Europe Dermatology Market by Country, 2016 - 2019, USD Million
  • TABLE 151 Europe Dermatology Market by Country, 2020 - 2026, USD Million
  • TABLE 152 Europe Other Therapeutic Area Market by Country, 2016 - 2019, USD Million
  • TABLE 153 Europe Other Therapeutic Area Market by Country, 2020 - 2026, USD Million
  • TABLE 154 Europe Cell Therapy Market by End User, 2016 - 2019, USD Million
  • TABLE 155 Europe Cell Therapy Market by End User, 2020 - 2026, USD Million
  • TABLE 156 Europe Academic & Research Institutes Market by Country, 2016 - 2019, USD Million
  • TABLE 157 Europe Academic & Research Institutes Market by Country, 2020 - 2026, USD Million
  • TABLE 158 Europe Hospitals & Clinics Market by Country, 2016 - 2019, USD Million
  • TABLE 159 Europe Hospitals & Clinics Market by Country, 2020 - 2026, USD Million
  • TABLE 160 Europe Cell Therapy Market by Cell Type, 2016 - 2019, USD Million
  • TABLE 161 Europe Cell Therapy Market by Cell Type, 2020 - 2026, USD Million
  • TABLE 162 Europe Stem Cell Market by Country, 2016 - 2019, USD Million
  • TABLE 163 Europe Stem Cell Market by Country, 2020 - 2026, USD Million
  • TABLE 164 Europe Umbilical Cord-Derived Cell Market by Country, 2016 - 2019, USD Million
  • TABLE 165 Europe Umbilical Cord-Derived Cell Market by Country, 2020 - 2026, USD Million
  • TABLE 166 Europe Adipose-Derived Stem Cell Market by Country, 2016 - 2019, USD Million
  • TABLE 167 Europe Adipose-Derived Stem Cell Market by Country, 2020 - 2026, USD Million
  • TABLE 168 Europe Non-Stem Cell Market by Country, 2016 - 2019, USD Million
  • TABLE 169 Europe Non-Stem Cell Market by Country, 2020 - 2026, USD Million
  • TABLE 170 Europe Bone Marrow Cell Market by Country, 2016 - 2019, USD Million
  • TABLE 171 Europe Bone Marrow Cell Market by Country, 2020 - 2026, USD Million
  • TABLE 172 Europe Blood Cell Market by Country, 2016 - 2019, USD Million
  • TABLE 173 Europe Blood Cell Market by Country, 2020 - 2026, USD Million
  • TABLE 174 Europe Others Cell Market by Country, 2016 - 2019, USD Million
  • TABLE 175 Europe Others Cell Market by Country, 2020 - 2026, USD Million
  • TABLE 176 Europe Cell Therapy Market by Country, 2016 - 2019, USD Million
  • TABLE 177 Europe Cell Therapy Market by Country, 2020 - 2026, USD Million
  • TABLE 178 Germany Cell Therapy Market, 2016 - 2019, USD Million
  • TABLE 179 Germany Cell Therapy Market, 2020 - 2026, USD Million
  • TABLE 180 Germany Cell Therapy Market by Therapy Type, 2016 - 2019, USD Million
  • TABLE 181 Germany Cell Therapy Market by Therapy Type, 2020 - 2026, USD Million
  • TABLE 182 Germany Cell Therapy Market by Therapeutic Area, 2016 - 2019, USD Million
  • TABLE 183 Germany Cell Therapy Market by Therapeutic Area, 2020 - 2026, USD Million
  • TABLE 184 Germany Cell Therapy Market by End User, 2016 - 2019, USD Million
  • TABLE 185 Germany Cell Therapy Market by End User, 2020 - 2026, USD Million
  • TABLE 186 Germany Cell Therapy Market by Cell Type, 2016 - 2019, USD Million
  • TABLE 187 Germany Cell Therapy Market by Cell Type, 2020 - 2026, USD Million
  • TABLE 188 UK Cell Therapy Market, 2016 - 2019, USD Million
  • TABLE 189 UK Cell Therapy Market, 2020 - 2026, USD Million
  • TABLE 190 UK Cell Therapy Market by Therapy Type, 2016 - 2019, USD Million
  • TABLE 191 UK Cell Therapy Market by Therapy Type, 2020 - 2026, USD Million
  • TABLE 192 UK Cell Therapy Market by Therapeutic Area, 2016 - 2019, USD Million
  • TABLE 193 UK Cell Therapy Market by Therapeutic Area, 2020 - 2026, USD Million
  • TABLE 194 UK Cell Therapy Market by End User, 2016 - 2019, USD Million
  • TABLE 195 UK Cell Therapy Market by End User, 2020 - 2026, USD Million
  • TABLE 196 UK Cell Therapy Market by Cell Type, 2016 - 2019, USD Million
  • TABLE 197 UK Cell Therapy Market by Cell Type, 2020 - 2026, USD Million
  • TABLE 198 France Cell Therapy Market, 2016 - 2019, USD Million
  • TABLE 199 France Cell Therapy Market, 2020 - 2026, USD Million
  • TABLE 200 France Cell Therapy Market by Therapy Type, 2016 - 2019, USD Million
  • TABLE 201 France Cell Therapy Market by Therapy Type, 2020 - 2026, USD Million
  • TABLE 202 France Cell Therapy Market by Therapeutic Area, 2016 - 2019, USD Million
  • TABLE 203 France Cell Therapy Market by Therapeutic Area, 2020 - 2026, USD Million
  • TABLE 204 France Cell Therapy Market by End User, 2016 - 2019, USD Million
  • TABLE 205 France Cell Therapy Market by End User, 2020 - 2026, USD Million
  • TABLE 206 France Cell Therapy Market by Cell Type, 2016 - 2019, USD Million
  • TABLE 207 France Cell Therapy Market by Cell Type, 2020 - 2026, USD Million
  • TABLE 208 Russia Cell Therapy Market, 2016 - 2019, USD Million
  • TABLE 209 Russia Cell Therapy Market, 2020 - 2026, USD Million
  • TABLE 210 Russia Cell Therapy Market by Therapy Type, 2016 - 2019, USD Million
  • TABLE 211 Russia Cell Therapy Market by Therapy Type, 2020 - 2026, USD Million
  • TABLE 212 Russia Cell Therapy Market by Therapeutic Area, 2016 - 2019, USD Million
  • TABLE 213 Russia Cell Therapy Market by Therapeutic Area, 2020 - 2026, USD Million
  • TABLE 214 Russia Cell Therapy Market by End User, 2016 - 2019, USD Million
  • TABLE 215 Russia Cell Therapy Market by End User, 2020 - 2026, USD Million
  • TABLE 216 Russia Cell Therapy Market by Cell Type, 2016 - 2019, USD Million
  • TABLE 217 Russia Cell Therapy Market by Cell Type, 2020 - 2026, USD Million
  • TABLE 218 Spain Cell Therapy Market, 2016 - 2019, USD Million
  • TABLE 219 Spain Cell Therapy Market, 2020 - 2026, USD Million
  • TABLE 220 Spain Cell Therapy Market by Therapy Type, 2016 - 2019, USD Million
  • TABLE 221 Spain Cell Therapy Market by Therapy Type, 2020 - 2026, USD Million
  • TABLE 222 Spain Cell Therapy Market by Therapeutic Area, 2016 - 2019, USD Million
  • TABLE 223 Spain Cell Therapy Market by Therapeutic Area, 2020 - 2026, USD Million
  • TABLE 224 Spain Cell Therapy Market by End User, 2016 - 2019, USD Million
  • TABLE 225 Spain Cell Therapy Market by End User, 2020 - 2026, USD Million
  • TABLE 226 Spain Cell Therapy Market by Cell Type, 2016 - 2019, USD Million
  • TABLE 227 Spain Cell Therapy Market by Cell Type, 2020 - 2026, USD Million
  • TABLE 228 Italy Cell Therapy Market, 2016 - 2019, USD Million
  • TABLE 229 Italy Cell Therapy Market, 2020 - 2026, USD Million
  • TABLE 230 Italy Cell Therapy Market by Therapy Type, 2016 - 2019, USD Million
  • TABLE 231 Italy Cell Therapy Market by Therapy Type, 2020 - 2026, USD Million
  • TABLE 232 Italy Cell Therapy Market by Therapeutic Area, 2016 - 2019, USD Million
  • TABLE 233 Italy Cell Therapy Market by Therapeutic Area, 2020 - 2026, USD Million
  • TABLE 234 Italy Cell Therapy Market by End User, 2016 - 2019, USD Million
  • TABLE 235 Italy Cell Therapy Market by End User, 2020 - 2026, USD Million
  • TABLE 236 Italy Cell Therapy Market by Cell Type, 2016 - 2019, USD Million
  • TABLE 237 Italy Cell Therapy Market by Cell Type, 2020 - 2026, USD Million
  • TABLE 238 Rest of Europe Cell Therapy Market, 2016 - 2019, USD Million
  • TABLE 239 Rest of Europe Cell Therapy Market, 2020 - 2026, USD Million
  • TABLE 240 Rest of Europe Cell Therapy Market by Therapy Type, 2016 - 2019, USD Million
  • TABLE 241 Rest of Europe Cell Therapy Market by Therapy Type, 2020 - 2026, USD Million
  • TABLE 242 Rest of Europe Cell Therapy Market by Therapeutic Area, 2016 - 2019, USD Million
  • TABLE 243 Rest of Europe Cell Therapy Market by Therapeutic Area, 2020 - 2026, USD Million
  • TABLE 244 Rest of Europe Cell Therapy Market by End User, 2016 - 2019, USD Million
  • TABLE 245 Rest of Europe Cell Therapy Market by End User, 2020 - 2026, USD Million
  • TABLE 246 Rest of Europe Cell Therapy Market by Cell Type, 2016 - 2019, USD Million
  • TABLE 247 Rest of Europe Cell Therapy Market by Cell Type, 2020 - 2026, USD Million
  • TABLE 248 Asia Pacific Cell Therapy Market, 2016 - 2019, USD Million
  • TABLE 249 Asia Pacific Cell Therapy Market, 2020 - 2026, USD Million
  • TABLE 250 Asia Pacific Cell Therapy Market by Therapy Type, 2016 - 2019, USD Million
  • TABLE 251 Asia Pacific Cell Therapy Market by Therapy Type, 2020 - 2026, USD Million
  • TABLE 252 Asia Pacific Autologous Market by Country, 2016 - 2019, USD Million
  • TABLE 253 Asia Pacific Autologous Market by Country, 2020 - 2026, USD Million
  • TABLE 254 Asia Pacific Allogeneic Market by Country, 2016 - 2019, USD Million
  • TABLE 255 Asia Pacific Allogeneic Market by Country, 2020 - 2026, USD Million
  • TABLE 256 Asia Pacific Cell Therapy Market by Therapeutic Area, 2016 - 2019, USD Million
  • TABLE 257 Asia Pacific Cell Therapy Market by Therapeutic Area, 2020 - 2026, USD Million
  • TABLE 258 Asia Pacific Malignancies Market by Country, 2016 - 2019, USD Million
  • TABLE 259 Asia Pacific Malignancies Market by Country, 2020 - 2026, USD Million
  • TABLE 260 Asia Pacific Autoimmune Disorders Market by Country, 2016 - 2019, USD Million
  • TABLE 261 Asia Pacific Autoimmune Disorders Market by Country, 2020 - 2026, USD Million
  • TABLE 262 Asia Pacific Musculoskeletal Disorders Market by Country, 2016 - 2019, USD Million
  • TABLE 263 Asia Pacific Musculoskeletal Disorders Market by Country, 2020 - 2026, USD Million
  • TABLE 264 Asia Pacific Dermatology Market by Country, 2016 - 2019, USD Million
  • TABLE 265 Asia Pacific Dermatology Market by Country, 2020 - 2026, USD Million
  • TABLE 266 Asia Pacific Other Therapeutic Area Market by Country, 2016 - 2019, USD Million
  • TABLE 267 Asia Pacific Other Therapeutic Area Market by Country, 2020 - 2026, USD Million
  • TABLE 268 Asia Pacific Cell Therapy Market by End User, 2016 - 2019, USD Million
  • TABLE 269 Asia Pacific Cell Therapy Market by End User, 2020 - 2026, USD Million
  • TABLE 270 Asia Pacific Academic & Research Institutes Market by Country, 2016 - 2019, USD Million
  • TABLE 271 Asia Pacific Academic & Research Institutes Market by Country, 2020 - 2026, USD Million
  • TABLE 272 Asia Pacific Hospitals & Clinics Market by Country, 2016 - 2019, USD Million
  • TABLE 273 Asia Pacific Hospitals & Clinics Market by Country, 2020 - 2026, USD Million
  • TABLE 274 Asia Pacific Cell Therapy Market by Cell Type, 2016 - 2019, USD Million
  • TABLE 275 Asia Pacific Cell Therapy Market by Cell Type, 2020 - 2026, USD Million
  • TABLE 276 Asia Pacific Stem Cell Market by Country, 2016 - 2019, USD Million
  • TABLE 277 Asia Pacific Stem Cell Market by Country, 2020 - 2026, USD Million
  • TABLE 278 Asia Pacific Umbilical Cord-Derived Cell Market by Country, 2016 - 2019, USD Million
  • TABLE 279 Asia Pacific Umbilical Cord-Derived Cell Market by Country, 2020 - 2026, USD Million
  • TABLE 280 Asia Pacific Adipose-Derived Stem Cell Market by Country, 2016 - 2019, USD Million
  • TABLE 281 Asia Pacific Adipose-Derived Stem Cell Market by Country, 2020 - 2026, USD Million
  • TABLE 282 Asia Pacific Non-Stem Cell Market by Country, 2016 - 2019, USD Million
  • TABLE 283 Asia Pacific Non-Stem Cell Market by Country, 2020 - 2026, USD Million
  • TABLE 284 Asia Pacific Bone Marrow Cell Market by Country, 2016 - 2019, USD Million
  • TABLE 285 Asia Pacific Bone Marrow Cell Market by Country, 2020 - 2026, USD Million
  • TABLE 286 Asia Pacific Blood Cell Market by Country, 2016 - 2019, USD Million
  • TABLE 287 Asia Pacific Blood Cell Market by Country, 2020 - 2026, USD Million
  • TABLE 288 Asia Pacific Others Cell Market by Country, 2016 - 2019, USD Million
  • TABLE 289 Asia Pacific Others Cell Market by Country, 2020 - 2026, USD Million
  • TABLE 290 Asia Pacific Cell Therapy Market by Country, 2016 - 2019, USD Million
  • TABLE 291 Asia Pacific Cell Therapy Market by Country, 2020 - 2026, USD Million
  • TABLE 292 China Cell Therapy Market, 2016 - 2019, USD Million
  • TABLE 293 China Cell Therapy Market, 2020 - 2026, USD Million
  • TABLE 294 China Cell Therapy Market by Therapy Type, 2016 - 2019, USD Million
  • TABLE 295 China Cell Therapy Market by Therapy Type, 2020 - 2026, USD Million
  • TABLE 296 China Cell Therapy Market by Therapeutic Area, 2016 - 2019, USD Million
  • TABLE 297 China Cell Therapy Market by Therapeutic Area, 2020 - 2026, USD Million
  • TABLE 298 China Cell Therapy Market by End User, 2016 - 2019, USD Million
  • TABLE 299 China Cell Therapy Market by End User, 2020 - 2026, USD Million
  • TABLE 300 China Cell Therapy Market by Cell Type, 2016 - 2019, USD Million
  • TABLE 301 China Cell Therapy Market by Cell Type, 2020 - 2026, USD Million
  • TABLE 302 Japan Cell Therapy Market, 2016 - 2019, USD Million
  • TABLE 303 Japan Cell Therapy Market, 2020 - 2026, USD Million
  • TABLE 304 Japan Cell Therapy Market by Therapy Type, 2016 - 2019, USD Million
  • TABLE 305 Japan Cell Therapy Market by Therapy Type, 2020 - 2026, USD Million
  • TABLE 306 Japan Cell Therapy Market by Therapeutic Area, 2016 - 2019, USD Million
  • TABLE 307 Japan Cell Therapy Market by Therapeutic Area, 2020 - 2026, USD Million
  • TABLE 308 Japan Cell Therapy Market by End User, 2016 - 2019, USD Million
  • TABLE 309 Japan Cell Therapy Market by End User, 2020 - 2026, USD Million
  • TABLE 310 Japan Cell Therapy Market by Cell Type, 2016 - 2019, USD Million
  • TABLE 311 Japan Cell Therapy Market by Cell Type, 2020 - 2026, USD Million
  • TABLE 312 India Cell Therapy Market, 2016 - 2019, USD Million
  • TABLE 313 India Cell Therapy Market, 2020 - 2026, USD Million
  • TABLE 314 India Cell Therapy Market by Therapy Type, 2016 - 2019, USD Million
  • TABLE 315 India Cell Therapy Market by Therapy Type, 2020 - 2026, USD Million
  • TABLE 316 India Cell Therapy Market by Therapeutic Area, 2016 - 2019, USD Million
  • TABLE 317 India Cell Therapy Market by Therapeutic Area, 2020 - 2026, USD Million
  • TABLE 318 India Cell Therapy Market by End User, 2016 - 2019, USD Million
  • TABLE 319 India Cell Therapy Market by End User, 2020 - 2026, USD Million
  • TABLE 320 India Cell Therapy Market by Cell Type, 2016 - 2019, USD Million
  • TABLE 321 India Cell Therapy Market by Cell Type, 2020 - 2026, USD Million
  • TABLE 322 South Korea Cell Therapy Market, 2016 - 2019, USD Million
  • TABLE 323 South Korea Cell Therapy Market, 2020 - 2026, USD Million
  • TABLE 324 South Korea Cell Therapy Market by Therapy Type, 2016 - 2019, USD Million
  • TABLE 325 South Korea Cell Therapy Market by Therapy Type, 2020 - 2026, USD Million
  • TABLE 326 South Korea Cell Therapy Market by Therapeutic Area, 2016 - 2019, USD Million
  • TABLE 327 South Korea Cell Therapy Market by Therapeutic Area, 2020 - 2026, USD Million
  • TABLE 328 South Korea Cell Therapy Market by End User, 2016 - 2019, USD Million
  • TABLE 329 South Korea Cell Therapy Market by End User, 2020 - 2026, USD Million
  • TABLE 330 South Korea Cell Therapy Market by Cell Type, 2016 - 2019, USD Million
  • TABLE 331 South Korea Cell Therapy Market by Cell Type, 2020 - 2026, USD Million
  • TABLE 332 Singapore Cell Therapy Market, 2016 - 2019, USD Million
  • TABLE 333 Singapore Cell Therapy Market, 2020 - 2026, USD Million
  • TABLE 334 Singapore Cell Therapy Market by Therapy Type, 2016 - 2019, USD Million
  • TABLE 335 Singapore Cell Therapy Market by Therapy Type, 2020 - 2026, USD Million
  • TABLE 336 Singapore Cell Therapy Market by Therapeutic Area, 2016 - 2019, USD Million
  • TABLE 337 Singapore Cell Therapy Market by Therapeutic Area, 2020 - 2026, USD Million
  • TABLE 338 Singapore Cell Therapy Market by End User, 2016 - 2019, USD Million
  • TABLE 339 Singapore Cell Therapy Market by End User, 2020 - 2026, USD Million
  • TABLE 340 Singapore Cell Therapy Market by Cell Type, 2016 - 2019, USD Million
  • TABLE 341 Singapore Cell Therapy Market by Cell Type, 2020 - 2026, USD Million
  • TABLE 342 Malaysia Cell Therapy Market, 2016 - 2019, USD Million
  • TABLE 343 Malaysia Cell Therapy Market, 2020 - 2026, USD Million
  • TABLE 344 Malaysia Cell Therapy Market by Therapy Type, 2016 - 2019, USD Million
  • TABLE 345 Malaysia Cell Therapy Market by Therapy Type, 2020 - 2026, USD Million
  • TABLE 346 Malaysia Cell Therapy Market by Therapeutic Area, 2016 - 2019, USD Million
  • TABLE 347 Malaysia Cell Therapy Market by Therapeutic Area, 2020 - 2026, USD Million
  • TABLE 348 Malaysia Cell Therapy Market by End User, 2016 - 2019, USD Million
  • TABLE 349 Malaysia Cell Therapy Market by End User, 2020 - 2026, USD Million
  • TABLE 350 Malaysia Cell Therapy Market by Cell Type, 2016 - 2019, USD Million
  • TABLE 351 Malaysia Cell Therapy Market by Cell Type, 2020 - 2026, USD Million
  • TABLE 352 Rest of Asia Pacific Cell Therapy Market, 2016 - 2019, USD Million
  • TABLE 353 Rest of Asia Pacific Cell Therapy Market, 2020 - 2026, USD Million
  • TABLE 354 Rest of Asia Pacific Cell Therapy Market by Therapy Type, 2016 - 2019, USD Million
  • TABLE 355 Rest of Asia Pacific Cell Therapy Market by Therapy Type, 2020 - 2026, USD Million
  • TABLE 356 Rest of Asia Pacific Cell Therapy Market by Therapeutic Area, 2016 - 2019, USD Million
  • TABLE 357 Rest of Asia Pacific Cell Therapy Market by Therapeutic Area, 2020 - 2026, USD Million
  • TABLE 358 Rest of Asia Pacific Cell Therapy Market by End User, 2016 - 2019, USD Million
  • TABLE 359 Rest of Asia Pacific Cell Therapy Market by End User, 2020 - 2026, USD Million
  • TABLE 360 Rest of Asia Pacific Cell Therapy Market by Cell Type, 2016 - 2019, USD Million
  • TABLE 361 Rest of Asia Pacific Cell Therapy Market by Cell Type, 2020 - 2026, USD Million
  • TABLE 362 LAMEA Cell Therapy Market, 2016 - 2019, USD Million
  • TABLE 363 LAMEA Cell Therapy Market, 2020 - 2026, USD Million
  • TABLE 364 LAMEA Cell Therapy Market by Therapy Type, 2016 - 2019, USD Million
  • TABLE 365 LAMEA Cell Therapy Market by Therapy Type, 2020 - 2026, USD Million
  • TABLE 366 LAMEA Autologous Market by Country, 2016 - 2019, USD Million
  • TABLE 367 LAMEA Autologous Market by Country, 2020 - 2026, USD Million
  • TABLE 368 LAMEA Allogeneic Market by Country, 2016 - 2019, USD Million
  • TABLE 369 LAMEA Allogeneic Market by Country, 2020 - 2026, USD Million
  • TABLE 370 LAMEA Cell Therapy Market by Therapeutic Area, 2016 - 2019, USD Million
  • TABLE 371 LAMEA Cell Therapy Market by Therapeutic Area, 2020 - 2026, USD Million
  • TABLE 372 LAMEA Malignancies Market by Country, 2016 - 2019, USD Million
  • TABLE 373 LAMEA Malignancies Market by Country, 2020 - 2026, USD Million
  • TABLE 374 LAMEA Autoimmune Disorders Market by Country, 2016 - 2019, USD Million
  • TABLE 375 LAMEA Autoimmune Disorders Market by Country, 2020 - 2026, USD Million
  • TABLE 376 LAMEA Musculoskeletal Disorders Market by Country, 2016 - 2019, USD Million
  • TABLE 377 LAMEA Musculoskeletal Disorders Market by Country, 2020 - 2026, USD Million
  • TABLE 378 LAMEA Dermatology Market by Country, 2016 - 2019, USD Million
  • TABLE 379 LAMEA Dermatology Market by Country, 2020 - 2026, USD Million
  • TABLE 380 LAMEA Other Therapeutic Area Market by Country, 2016 - 2019, USD Million
  • TABLE 381 LAMEA Other Therapeutic Area Market by Country, 2020 - 2026, USD Million
  • TABLE 382 LAMEA Cell Therapy Market by End User, 2016 - 2019, USD Million
  • TABLE 383 LAMEA Cell Therapy Market by End User, 2020 - 2026, USD Million
  • TABLE 384 LAMEA Academic & Research Institutes Market by Country, 2016 - 2019, USD Million
  • TABLE 385 LAMEA Academic & Research Institutes Market by Country, 2020 - 2026, USD Million
  • TABLE 386 LAMEA Hospitals & Clinics Market by Country, 2016 - 2019, USD Million
  • TABLE 387 LAMEA Hospitals & Clinics Market by Country, 2020 - 2026, USD Million
  • TABLE 388 LAMEA Cell Therapy Market by Cell Type, 2016 - 2019, USD Million
  • TABLE 389 LAMEA Cell Therapy Market by Cell Type, 2020 - 2026, USD Million
  • TABLE 390 LAMEA Stem Cell Market by Country, 2016 - 2019, USD Million
  • TABLE 391 LAMEA Stem Cell Market by Country, 2020 - 2026, USD Million
  • TABLE 392 LAMEA Umbilical Cord-Derived Cell Market by Country, 2016 - 2019, USD Million
  • TABLE 393 LAMEA Umbilical Cord-Derived Cell Market by Country, 2020 - 2026, USD Million
  • TABLE 394 LAMEA Adipose-Derived Stem Cell Market by Country, 2016 - 2019, USD Million
  • TABLE 395 LAMEA Adipose-Derived Stem Cell Market by Country, 2020 - 2026, USD Million
  • TABLE 396 LAMEA Non-Stem Cell Market by Country, 2016 - 2019, USD Million
  • TABLE 397 LAMEA Non-Stem Cell Market by Country, 2020 - 2026, USD Million
  • TABLE 398 LAMEA Bone Marrow Cell Market by Country, 2016 - 2019, USD Million
  • TABLE 399 LAMEA Bone Marrow Cell Market by Country, 2020 - 2026, USD Million
  • TABLE 400 LAMEA Blood Cell Market by Country, 2016 - 2019, USD Million
  • TABLE 401 LAMEA Blood Cell Market by Country, 2020 - 2026, USD Million
  • TABLE 402 LAMEA Others Cell Market by Country, 2016 - 2019, USD Million
  • TABLE 403 LAMEA Others Cell Market by Country, 2020 - 2026, USD Million
  • TABLE 404 LAMEA Cell Therapy Market by Country, 2016 - 2019, USD Million
  • TABLE 405 LAMEA Cell Therapy Market by Country, 2020 - 2026, USD Million
  • TABLE 406 Brazil Cell Therapy Market, 2016 - 2019, USD Million
  • TABLE 407 Brazil Cell Therapy Market, 2020 - 2026, USD Million
  • TABLE 408 Brazil Cell Therapy Market by Therapy Type, 2016 - 2019, USD Million
  • TABLE 409 Brazil Cell Therapy Market by Therapy Type, 2020 - 2026, USD Million
  • TABLE 410 Brazil Cell Therapy Market by Therapeutic Area, 2016 - 2019, USD Million
  • TABLE 411 Brazil Cell Therapy Market by Therapeutic Area, 2020 - 2026, USD Million
  • TABLE 412 Brazil Cell Therapy Market by End User, 2016 - 2019, USD Million
  • TABLE 413 Brazil Cell Therapy Market by End User, 2020 - 2026, USD Million
  • TABLE 414 Brazil Cell Therapy Market by Cell Type, 2016 - 2019, USD Million
  • TABLE 415 Brazil Cell Therapy Market by Cell Type, 2020 - 2026, USD Million
  • TABLE 416 Argentina Cell Therapy Market, 2016 - 2019, USD Million
  • TABLE 417 Argentina Cell Therapy Market, 2020 - 2026, USD Million
  • TABLE 418 Argentina Cell Therapy Market by Therapy Type, 2016 - 2019, USD Million
  • TABLE 419 Argentina Cell Therapy Market by Therapy Type, 2020 - 2026, USD Million
  • TABLE 420 Argentina Cell Therapy Market by Therapeutic Area, 2016 - 2019, USD Million
  • TABLE 421 Argentina Cell Therapy Market by Therapeutic Area, 2020 - 2026, USD Million
  • TABLE 422 Argentina Cell Therapy Market by End User, 2016 - 2019, USD Million
  • TABLE 423 Argentina Cell Therapy Market by End User, 2020 - 2026, USD Million
  • TABLE 424 Argentina Cell Therapy Market by Cell Type, 2016 - 2019, USD Million
  • TABLE 425 Argentina Cell Therapy Market by Cell Type, 2020 - 2026, USD Million
  • TABLE 426 UAE Cell Therapy Market, 2016 - 2019, USD Million
  • TABLE 427 UAE Cell Therapy Market, 2020 - 2026, USD Million
  • TABLE 428 UAE Cell Therapy Market by Therapy Type, 2016 - 2019, USD Million
  • TABLE 429 UAE Cell Therapy Market by Therapy Type, 2020 - 2026, USD Million
  • TABLE 430 UAE Cell Therapy Market by Therapeutic Area, 2016 - 2019, USD Million
  • TABLE 431 UAE Cell Therapy Market by Therapeutic Area, 2020 - 2026, USD Million
  • TABLE 432 UAE Cell Therapy Market by End User, 2016 - 2019, USD Million
  • TABLE 433 UAE Cell Therapy Market by End User, 2020 - 2026, USD Million
  • TABLE 434 UAE Cell Therapy Market by Cell Type, 2016 - 2019, USD Million
  • TABLE 435 UAE Cell Therapy Market by Cell Type, 2020 - 2026, USD Million
  • TABLE 436 Saudi Arabia Cell Therapy Market, 2016 - 2019, USD Million
  • TABLE 437 Saudi Arabia Cell Therapy Market, 2020 - 2026, USD Million
  • TABLE 438 Saudi Arabia Cell Therapy Market by Therapy Type, 2016 - 2019, USD Million
  • TABLE 439 Saudi Arabia Cell Therapy Market by Therapy Type, 2020 - 2026, USD Million
  • TABLE 440 Saudi Arabia Cell Therapy Market by Therapeutic Area, 2016 - 2019, USD Million
  • TABLE 441 Saudi Arabia Cell Therapy Market by Therapeutic Area, 2020 - 2026, USD Million
  • TABLE 442 Saudi Arabia Cell Therapy Market by End User, 2016 - 2019, USD Million
  • TABLE 443 Saudi Arabia Cell Therapy Market by End User, 2020 - 2026, USD Million
  • TABLE 444 Saudi Arabia Cell Therapy Market by Cell Type, 2016 - 2019, USD Million
  • TABLE 445 Saudi Arabia Cell Therapy Market by Cell Type, 2020 - 2026, USD Million
  • TABLE 446 South Africa Cell Therapy Market, 2016 - 2019, USD Million
  • TABLE 447 South Africa Cell Therapy Market, 2020 - 2026, USD Million
  • TABLE 448 South Africa Cell Therapy Market by Therapy Type, 2016 - 2019, USD Million
  • TABLE 449 South Africa Cell Therapy Market by Therapy Type, 2020 - 2026, USD Million
  • TABLE 450 South Africa Cell Therapy Market by Therapeutic Area, 2016 - 2019, USD Million
  • TABLE 451 South Africa Cell Therapy Market by Therapeutic Area, 2020 - 2026, USD Million
  • TABLE 452 South Africa Cell Therapy Market by End User, 2016 - 2019, USD Million
  • TABLE 453 South Africa Cell Therapy Market by End User, 2020 - 2026, USD Million
  • TABLE 454 South Africa Cell Therapy Market by Cell Type, 2016 - 2019, USD Million
  • TABLE 455 South Africa Cell Therapy Market by Cell Type, 2020 - 2026, USD Million
  • TABLE 456 Nigeria Cell Therapy Market, 2016 - 2019, USD Million
  • TABLE 457 Nigeria Cell Therapy Market, 2020 - 2026, USD Million
  • TABLE 458 Nigeria Cell Therapy Market by Therapy Type, 2016 - 2019, USD Million
  • TABLE 459 Nigeria Cell Therapy Market by Therapy Type, 2020 - 2026, USD Million
  • TABLE 460 Nigeria Cell Therapy Market by Therapeutic Area, 2016 - 2019, USD Million
  • TABLE 461 Nigeria Cell Therapy Market by Therapeutic Area, 2020 - 2026, USD Million
  • TABLE 462 Nigeria Cell Therapy Market by End User, 2016 - 2019, USD Million
  • TABLE 463 Nigeria Cell Therapy Market by End User, 2020 - 2026, USD Million
  • TABLE 464 Nigeria Cell Therapy Market by Cell Type, 2016 - 2019, USD Million
  • TABLE 465 Nigeria Cell Therapy Market by Cell Type, 2020 - 2026, USD Million
  • TABLE 466 Rest of LAMEA Cell Therapy Market, 2016 - 2019, USD Million
  • TABLE 467 Rest of LAMEA Cell Therapy Market, 2020 - 2026, USD Million
  • TABLE 468 Rest of LAMEA Cell Therapy Market by Therapy Type, 2016 - 2019, USD Million
  • TABLE 469 Rest of LAMEA Cell Therapy Market by Therapy Type, 2020 - 2026, USD Million
  • TABLE 470 Rest of LAMEA Cell Therapy Market by Therapeutic Area, 2016 - 2019, USD Million
  • TABLE 471 Rest of LAMEA Cell Therapy Market by Therapeutic Area, 2020 - 2026, USD Million
  • TABLE 472 Rest of LAMEA Cell Therapy Market by End User, 2016 - 2019, USD Million
  • TABLE 473 Rest of LAMEA Cell Therapy Market by End User, 2020 - 2026, USD Million
  • TABLE 474 Rest of LAMEA Cell Therapy Market by Cell Type, 2016 - 2019, USD Million
  • TABLE 475 Rest of LAMEA Cell Therapy Market by Cell Type, 2020 - 2026, USD Million
  • TABLE 476 Key Information - Fujifilm Holdings Corporation
  • TABLE 477 key Information - Smith & Nephew PLC
  • TABLE 478 key information - Kolon TissueGene, Inc.
  • TABLE 479 Key Information - JCR Pharmaceuticals Co., Ltd.
  • TABLE 480 Key Information - Medipost Co., Ltd.
  • TABLE 481 key Information - Stemedica Cell Technologies, Inc.
  • TABLE 482 Key Information - NuVasive, Inc.
  • TABLE 483 key information - Avantor, Inc.
  • TABLE 484 Key Information - Vericel Corporation
  • TABLE 485 Key Information - Pharmicell Co., Ltd.

List of Figures

  • FIG 1 Methodology for the research
  • FIG 2 KBV Cardinal Matrix
  • FIG 3 Key Leading Strategies: Percentage Distribution (2016-2020)
  • FIG 4 Recent strategies and developments: Fujifilm Holdings Corporation
  • FIG 5 Recent strategies and developments: Smith & Nephew PLC
  • FIG 6 Recent strategies and developments: JCR Pharmaceuticals Co., Ltd.
  • FIG 7 Recent strategies and developments: Avantor, Inc.
  • FIG 8 Recent strategies and developments: Vericel Corporation